Torque Capital Group’s J-Pac Names New President/CEO

J-Pac, a portfolio company of Torque Capital Group, said Tuesday that it has named Mark Florence as president and CEO. Previously, Florence worked at Abbott Laboratories, Bayer, McKesson and most recently, NxStage Medical. Headquartered in Somersworth, New Hampshire, J-Pac is a medical manufacturing company.


SOMERSWORTH, N.H.–(BUSINESS WIRE)–J-Pac, a full-service contract manufacturing company servicing the medical device, diagnostics, pharmaceutical and life sciences industries, today announced the appointment of Mark Florence as incoming President and Chief Executive Officer. Florence brings to the company nearly 30 years of industry experience in product development, improvement and commercialization in both large and small organizations.
“We believe Mark’s proven track record of meeting customer needs will accelerate J-Pac’s growth and leadership in medical device manufacturing,” said Joseph Parzick, J-Pac Chairman of the Board. “He is an industry veteran who understands the importance of delivering on commitments, and we are confident that his leadership, collaborative style and commitment to the customer experience will be a tremendous asset to our team.”
Prior to joining J-Pac, Florence held various leadership roles at Abbott Laboratories, Bayer, McKesson, and most recently, NxStage Medical. He earned Bachelor of Science and Master of Business Administration degrees from Northeastern University. In his new role, Florence will lead J-Pac as the Company applies its proprietary manufacturing processes to help customers grow existing markets and capitalize on new opportunities through innovation, enhanced efficiency and speed-to-market.
“J-Pac is an exciting and growing organization with a tremendous opportunity to help its business partners improve patient outcomes,” said Florence. “I look forward to working with our team to advance this mission and explore new opportunities to empower our customers so that they can achieve their objectives.”
About J-Pac Manufacturing & Packaging
J-Pac is an innovative contract manufacturing company serving the medical device, diagnostics, pharmaceutical, and life sciences industries. The Company manages projects from the initial stages of packaging and prototype design through clinical trials and full-scale production. By working collaboratively with clients, J-Pac helps reduce time to market, ensure effective product launches and provide validated processes for scale-up to full production. The Company’s custom manufacturing and packaging capabilities include point-of-care diagnostic testing, implantable textile manufacturing and packaging, cardiovascular, surgical and orthopedic device assembly and sheet and web converting – including tray forming, wound care dressing, die-cutting and oral strip converting. For more information, visit the J-Pac Web site at
About Torque Capital Group
J-Pac is owned by the Torque Capital Group, a New York based private equity firm that actively partners with leading industrial players and high-quality management teams to invest in best-in-class manufacturing businesses.